AVTX Amendment: Millennium Reports 9,857 Shared Shares

Rhea-AI Filing Summary

Avalo Therapeutics, Inc. receives a Schedule 13G/A amendment disclosing that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report shared voting and shared dispositive power over 9,857 shares of Avalo common stock (CUSIP 05338F306). The filing lists shared voting and shared dispositive power of 9,857 and reports 0.0% of the class. The cover information is signed under a Joint Filing Agreement dated July 2, 2026.

Insights

Corporate Governance Analyst

Passive ownership disclosure by an investment manager reporting shared control of 9,857 shares.

The amendment lists Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander as joint filers holding shared voting and dispositive power for 9,857 shares. The filing clarifies that those shares are held by entities subject to the filers' voting control or investment discretion.

Items to watch in subsequent filings include any change in reported share counts or percent of class; the Joint Filing Agreement is attached and dated July 2, 2026.

Key Figures

Shared voting power: 9,857 shares Shared dispositive power: 9,857 shares Percent of class: 0.0% +1 more

4 metrics

Shared voting power 9,857 shares reported on Schedule 13G/A cover pages

Shared dispositive power 9,857 shares reported on Schedule 13G/A cover pages

Percent of class 0.0% reported on Schedule 13G/A cover pages

Joint Filing Agreement date July 2, 2026 Exhibit I to the amendment

Key Terms

Joint Filing Agreement, beneficially owned, shared dispositive power

3 terms

Joint Filing Agreement regulatory

"Exhibit I: Joint Filing Agreement, dated as of July 2, 2026"

beneficially owned regulatory

"Amount beneficially owned: See response to Item 9 on each cover page."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared dispositive power financial

"Shared Dispositive Power 9,857.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AVTX Schedule 13G/A amendment disclose?

It discloses that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report shared voting and dispositive power over 9,857 shares. The cover lists CUSIP 05338F306 and the Joint Filing Agreement dated July 2, 2026.

Who are the joint filers named on the AVTX amendment?

The joint filers are Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. Addresses for the filers are shown as 399 Park Avenue, New York, New York, and signatures are dated July 2, 2026.

How many Avalo shares are reported and what percentage of the class is that?

The filing reports shared voting and shared dispositive power over 9,857 shares and lists the percent of class as 0.0%. The filing ties these counts to Item responses on the cover pages.

Does the filing state who directly holds the disclosed shares?

The filing explains the shares are held by entities subject to voting control and investment discretion by the filers. It also states this should not be construed as an admission of beneficial ownership by the filers.

Is there an agreement among the filers in this filing?

Yes. The filing includes a Joint Filing Agreement among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, dated July 2, 2026, as Exhibit I to the amendment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 05:29 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Avalo Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

05338F306

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 05338F306

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,857.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,857.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,857.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 05338F306

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,857.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,857.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,857.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 05338F306

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,857.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,857.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,857.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Avalo Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 1500 Liberty Ridge Drive, Suite 321, Wayne, Pennsylvania 19087
Item 2.
(a)	Name of person filing: Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 05338F306
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/02/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/02/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	07/02/2026

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of July 2, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.